References
- Stogner JM, Miller BL. Assessing the dangers of “dabbing”: mere marijuana or harmful new trend? Pediatrics. 2015;136(1):1–3. doi:10.1542/peds.2015-0454.
- Conrad C. Hash oil, BHO, chemical solvent extraction laws. 2016 Dec 16 [accessed 2018 Jan 22]. http://chrisconrad.com/2016/12/hash-oil-bho-chemical-solvent-extraction-laws.
- Kaspero B. Marijuana hash oil laws in California. 2016 [accessed 2018 Jan 22]. http://www.bartkasperolaw.com/drug-charges/laws/manufacturing-hash-oil/.
- Friedman G. Legal marijuana competes with hash-oil black market. Washington Times [newspaper on the Internet]. 2015 July 20 [accessed 2018 Jan 22]. https://www.washingtontimes.com/news/2015/jul/20/legal-marijuana-competes-with-hash-oil-black-marke/.
- Washington State Legislature [Internet]. Marijuana processor license extraction requirements. [ accessed 2018 Jan 22]. http://apps.leg.wa.gov/wac/default.aspx?cite=314-55-104.
- Drug Enforcement Administration. What you should know about marijuana concentrates. 2014 Dec [accessed 2018 Jan 22]. https://www.dea.gov/pr/multimedia-library/publications/marijuana-concentrates.pdf.
- State of Colorado [Internet]. Safety with hash oil. 2018 [accessed 2018 Jan 22]. https://www.colorado.gov/pacific/marijuana/safety-hash-oil.
- Leonhart MM. National drug threat assessment summary. 2014 Nov. United States Department of Justice Drug Enforcement Administration, Strategic Intelligence Section. DEA-DCT-DIR-002-15. https://www.dea.gov/resource-center/dir-ndta-unclass.pdf.
- Elzinga S, Fischedick J, Podkolinski R, Raber J. Cannabinoids and terpenes as chemotaxonomic markers in cannabis. Nat Prod Chem Res. 2015;3(181):10.4172. doi:10.4172/2329-6836.1000181.
- Raber JC, Elzinga S, Kaplan C. Understanding dabs: contamination concerns of cannabis concentrates and cannabinoid transfer during the act of dabbing. J Toxicol Sci. 2015;40(6):797–803. doi:10.2131/jts.40.797.
- Romano LL, Hazekamp A. Cannabis oil: chemical evaluation of an upcoming cannabis- based medicine. Cannaboids. 2013;7(1):1–11.
- Loflin M, Earleywine M. A new method of cannabis ingestion: the dangers of dabs? Addict Behav. 2014;39(10):1430–33. doi:10.1016/j.addbeh.2014.05.013.
- Meier MH. Associations between butane hash oil use and cannabis-related problems. Drug Alcohol Depend. 2017;179:25–31. doi:10.1016/j.drugalcdep.2017.06.015.
- Chan GCK, Hall W, Freeman TP, Ferris J, Kelly AB, Winstock A. User characteristics and effect profile of butane hash oil: an extremely high-potency cannabis concentrate. Drug Alcohol Depend. 2017;178:32–38. doi:10.1016/j.drugalcdep.2017.04.014.
- Daniulaityte R, Lamy FR, Barratt M, Nahhas RW, Martins SS, Boyer EW, Sheth A, Carlson RG. Characterizing marijuana concentrate users: a web-based survey. Drug Alcohol Depend. 2017;178:399–407. doi:10.1016/j.drugalcdep.2017.05.034.
- United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality. National Survey on Drug Use and Health, 2014. ICPSR36361-v1. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], 2016- 03-22. doi:10.3886/ICPSR36361.v1.
- Krauss MJ, Sowles SJ, Sehi A, Spitznagel EL, Berg CJ, Bierut LJ, Cavazos-Rehg PA. Marijuana advertising exposure among current marijuana users in the US. Drug Alcohol Depend. 2017;174:192–200. doi: 10.1016/j.drugalcdep.2017.01.017.
- Marijuana Policy Project. Key aspects of state and D.C. medical marijuana laws. 2017 Aug 2 [accessed 2018 Jan 22]. https://www.mpp.org/issues/medical-marijuana/state-by-state-medical-marijuana-laws/key-aspects-of-state-and-d-c-medical-marijuana-laws/.
- NORML. State laws. [ accessed 2018 Jan 22]. http://norml.org/laws.
- Armstrong RA. When to use the Bonferroni correction. Ophthalmic Physiol Opt. 2014;34(5):502–08. doi:10.1111/opo.12131.
- Streiner DL, Norman GR. Correction for multiple testing: is there a resolution? Chest. 2011;140(1):16–18. doi:10.1378/chest.11-0523.
- Schulz KF, Grimes DA. Multiplicity in randomised trials I: endpoints and treatments. Lancet. 2005;365(9470):1591–95. doi:10.1016/s0140-6736(05)66461-6.
- Krauss MJ, Grucza RA, Bierut LJ,Cavazos-Rehg PA. “Get Drunk. Smoke weed. Have fun.”: A content analysis of tweets about marijuana and alcohol. Am J Health Promot. 2017;31(3):200–8. doi: 10.4278/ajhp.150205-QUAL-708
- Cavazos-Rehg PA, Krauss M, Fisher SL, Salyer P, Grucza RA, Bierut LJ. Twitter chatter about marijuana. J. Adolesc. Health. 2015;56(2):139–45. doi: 10.1016/j.jadohealth.2014.10.270
- Whiting PF, Wolff RF, Deshpande S, Di Nisio M, Dufy S, Hernandez AV, et al. Cannabinoids for medical use: a systematic review and meta-analysis. Jama. 2015;313(24):2456–73. doi:10.1001/jama.2015.6358.
- Freeman TP, Winstock AR. Examining the profile of high-potency cannabis and its association with severity of cannabis dependence. Psychol Med. 2015;45(15):3181–89. doi:10.1017/S0033291715001178.
- Cavazos-Rehg PA, Sowles SJ, Krauss MJ, Agbonavbare V, Grucza R, Bierut L. A Content analysis of tweets about high-potency marijuana. Drug Alcohol Depend. 2016;166:100–8. doi: 10.1016/j.drugalcdep.2016.06.034.
- Volkow ND, Compton WM, Weiss SR. Adverse health effects of marijuana use. N Engl J Med. 2014;371(9):879.
- Krauss MJ, Rajbhandari B, Sowles SJ, Spitznagel EL,Cavazos-Rehg P. A latent class analysis of poly-marijuana use among young adults. Addict Behav. 2017;75:159-65. doi: 10.1016/j.addbeh.2017.07.021.
- Mccabe SE, West BT, Schepis TS, Teter CJ. Simultaneous and concurrent polydrug use of alcohol and prescription drugs: prevalence, correlates, and consequences. Hum Psychopharmacol. 2015;30(1):42–51. doi:10.1002/hup.2449.
- Hartman RL, Brown TL, Milavetz G, Spurgin A, Gorelick DA, Gaffney G, Huestis MA. Controlled cannabis vaporizer administration: blood and plasma cannabinoids with and without alcohol. Clin Chem. 2015;61(6):850–69. doi:10.1373/clinchem.2015.238287.
- Jones J, Jones KN, Peil J. The impact of the legalization of recreational marijuana on college students. Addict Behav. 2018;77:255–59. doi:10.1016/j.addbeh.2017.08.015.
- Wronski L, Liu M. Calibrating cross-national panel surveys. [PowerPoint presentation]. International Conference on Survey Methods in Multinational, Multiregional and Multicultural Contexts (3MC); 2016 July 27 [accessed 2017 June 30]. https://csdiworkshop.org/images/2016_3MC_Presentations/Wronski_Calibrating-Cross-National-Panel-Surveys.pdf.
- Van Dam NT, Earleywine M, DiGiacomo G. Polydrug use, cannabis, and psychosis-like symptoms. Hum Psychopharmacol. 2008;23(6):475–85. doi:10.1002/hup.950.
- Borodovsky JT, Crosier BS, Lee DC, Sargent JD, Budney AJ. Smoking, vaping, eating: is legalization impacting the way people use cannabis? Int J Drug Policy. 2016;36:141–47. doi:10.1016/j.drugpo.2016.02.022.
- Daniulaityte R, Nahhas RW, Wijeratne S, Carlson RG, Lamy FR, Martins SS, Boyer EW, et al. “Time for dabs”: analyzing Twitter data on marijuana concentrates across the U.S. Drug Alcohol Depend. 2015;155:307–11. doi:10.1016/j.drugalcdep.2015.07.1199.
- Baker R, Blumberg SJ, Brick JM, Couper MP, Courtright M, Dennis JM, Dillman D, et al. Research synthesis: AAPOR report on online panels. Public Opin Q. 2010;74(4):711–81. doi:10.1093/poq/nfq048.
- Wright KB. Researching internet-based populations: advantages and disadvantages of online survey research, online questionnaire authoring software packages, and web survey services. J Comput Mediat Commun. 2005;10(3):00–00. doi:10.1111/j.1083-6101.2005.tb00259.x.